The first senolytic drugs to target senescent cells
Mayo Clinic - 05-Sep-2017New platform will help to identify additional drugs that target ageing processes more quickly
Megan Forliti
Mayo Clinic Contributor
Regular contributor to Mayo Clinic Magazine.
Visit website: https://advancingthescience.mayo.edu/member/mforliti/
Details last updated 08-Jul-2019
Articles written by Megan Forliti
CD38 enzyme: the culprit behind age related metabolic diseases
Mayo Clinic - 14-Jun-2016The focus is to find ways to keep up the NAD levels in tissues with ageing